Specifically, the expression of monocytes, M1, M2, and FcγRIII (CD16) and the secretion of IL-6, IL-27, and IL-13 suggested that M-IVIG was better than F-IVIG and Mix-IVIG in improving ITP. This evidence concerns the gene IL6 and autoimmune thrombocytopenic purpura.